Wednesday - March 25, 2026
FDA Center for Biologics Evaluation & Research Issues Warning Letter to Yangzhou H&R Plastic Daily Chemical
March 25, 2026
WASHINGTON, March 25 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Yangzhou H&R Plastic Daily Chemical Co. Ltd. from its Center for Drug Evaluation and Research:

* * *

Recipient: Mr. Jingcheng Gao, General Manager, Yangzhou H&R Plastic Daily Chemical Co., Ltd., 188 Xingyuan Road Hangji, Guangling Qu Yangzhou Shi Jiangsu Sheng, 225111, China

Issuing Office: Center for Drug Eval . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products